Skip to main content
Guhan Pharmaceutical Group Co., Ltd. logo

Guhan Pharmaceutical Group Co., Ltd. — Investor Relations & Filings

Ticker · 000590 ISIN · CNE000000701 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,714 across all filing types
Latest filing 2019-04-19 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 000590

About Guhan Pharmaceutical Group Co., Ltd.

https://www.tuspharma.cn

Guhan Pharmaceutical Group Co., Ltd. specializes in the research, development, production, and sale of traditional Chinese medicine (TCM) and health-related products. The company is widely recognized for its flagship product, Guhan Yangsheng Jing, which is formulated based on ancient health preservation prescriptions discovered in the Mawangdui Han Dynasty Tombs. Its product portfolio includes oral liquids, tablets, and capsules designed to enhance vitality, support kidney function, and promote overall longevity. The organization integrates classical medical theories with modern pharmaceutical manufacturing processes to ensure product efficacy and safety. Beyond its core TCM offerings, the group engages in the production of chemical drugs and health supplements, targeting markets seeking natural wellness solutions. The company emphasizes the preservation of cultural heritage through the modernization of ancient medical wisdom.

Recent filings

Filing Released Lang Actions
关于终止实施部分募集资金投资项目的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from a company regarding the termination of part of its fundraising investment projects. It details the background of the fundraising, the specific project being terminated, reasons for termination, and the impact on the company and shareholders. It also includes opinions from independent directors, the supervisory board, and the sponsoring institution. The document is relatively short (3106 characters) and does not contain financial statements or detailed financial data. It is an update on the use of capital raised through a non-public stock issuance and changes to the investment plan for those funds. This fits the description of a Capital/Financing Update (CAP) as it relates to changes in the use of raised capital and investment projects funded by that capital. It is not a full financial report, audit, or regulatory filing, nor is it a voting result or management change announcement.
2019-04-19 Chinese
2019年第一季度业绩预告
Earnings Release Classification · 95% confidence The document is a quarterly earnings forecast for the first quarter of 2019, providing estimated net profit and earnings per share, with a disclaimer that the data is preliminary and unaudited. It explicitly states that the final data will be in the formal quarterly report. The document length is short (706 characters) and it is an announcement of expected financial results rather than a full financial report with actual financial statements or detailed analysis. Therefore, it fits the definition of an Earnings Release (ER), which is an initial announcement of quarterly financial results with key highlights only. Q1 2019
2019-04-12 Chinese
2018年度业绩快报
Earnings Release Classification · 95% confidence The document is titled '2018 年度业绩快报' which translates to '2018 Annual Performance Express Report' or '2018 Earnings Quick Report'. It contains preliminary financial data for the year 2018, including revenue, profit, net income, earnings per share, and other financial metrics. The document explicitly states that these are preliminary figures and not the final audited annual report. It also mentions that the full 2018 annual report will be published later (on April 20, 2019). The document is relatively short (1485 characters) and serves as an initial earnings release or quick performance update rather than a full annual report. This matches the definition of an Earnings Release (ER), which is an initial announcement of quarterly or periodical financial results with key highlights only. Therefore, the correct classification is Earnings Release (ER). FY 2018
2019-04-12 Chinese
关于使用部分闲置募集资金购买的理财产品到期赎回并继续进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from a company regarding the use of idle raised funds to purchase and redeem financial products, specifically bank certificates of deposit and structured deposits. It details the amounts, dates, returns, and risk control measures related to these financial products. The document also references prior board and shareholder approvals for these actions. The content is focused on updates about financing activities and cash management rather than a full financial report, earnings release, or regulatory filing. It is not a report publication announcement since it contains substantive details about the transactions and ongoing management of funds. Therefore, the document fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes.
2019-04-07 Chinese
股票交易异常波动公告
Regulatory Filings Classification · 95% confidence The document is a stock trading abnormal fluctuation announcement by the company 启迪古汉集团股份有限公司. It discusses the unusual price movements of the company's stock over a few days, the company's investigation into the cause, confirmation of no undisclosed material information, and references to previously published announcements about terminated major asset restructuring and indirect controlling shareholder equity changes. It also includes risk warnings and a reminder about the company's 2018 earnings forecast. The document is relatively short (1992 characters) and serves as a regulatory disclosure about stock price movements and related corporate events rather than a financial report or detailed analysis. It does not contain financial statements or detailed financial data. Therefore, it fits best into the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other specific categories.
2019-04-01 Chinese
股票交易异常波动公告
Regulatory Filings Classification · 95% confidence The document is titled '股票交易异常波动公告' which translates to 'Announcement of Abnormal Stock Trading Fluctuations'. It discusses the unusual stock price movements over two trading days, the company's investigation into the matter, confirmation of no undisclosed material information, and references to previously disclosed announcements. It does not contain financial statements or detailed financial data but is an announcement related to stock price behavior and regulatory compliance. The document length is short (1994 characters) and it serves as a regulatory disclosure about stock trading anomalies rather than a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS).
2019-03-27 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.